Page last updated: 2024-08-26

mci 9038 and Mandibular Neoplasms

mci 9038 has been researched along with Mandibular Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ito, S; McAlister, RK	1

Other Studies

1 other study(ies) available for mci 9038 and Mandibular Neoplasms

Article	Year
Minimal Prolongation of Prothrombin Time with Extended Exposure to Argatroban. Pharmacotherapy, 2015, Volume: 35, Issue:7 Topics: Anticoagulants; Antithrombins; Arginine; Carcinoma, Squamous Cell; Drug Substitution; Female; Heparin; Humans; International Normalized Ratio; Mandibular Neoplasms; Middle Aged; Mouth Mucosa; Pipecolic Acids; Prothrombin Time; Sulfonamides; Syndrome; Thrombocytopenia; Thrombosis; Treatment Failure; Warfarin	2015

Article

Year

Minimal Prolongation of Prothrombin Time with Extended Exposure to Argatroban.

Pharmacotherapy, 2015, Volume: 35, Issue:7

Topics: Anticoagulants; Antithrombins; Arginine; Carcinoma, Squamous Cell; Drug Substitution; Female; Heparin; Humans; International Normalized Ratio; Mandibular Neoplasms; Middle Aged; Mouth Mucosa; Pipecolic Acids; Prothrombin Time; Sulfonamides; Syndrome; Thrombocytopenia; Thrombosis; Treatment Failure; Warfarin

2015